{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:13:02Z","timestamp":1785031982075,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss National foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients suffering from mental disorders are at high risk of developing cardiovascular diseases, leading to a reduction in life expectancy. Genetic variants can display greater influence on cardiometabolic features in psychiatric cohorts compared to the general population. The difference is possibly due to an intricate interaction between the mental disorder or the medications used to treat it and metabolic regulations. Previous genome wide association studies (GWAS) on antipsychotic-induced weight gain included a low number of participants and\/or were restricted to patients taking one specific antipsychotic. We conducted a GWAS of the evolution of body mass index (BMI) during early (i.e., \u2264\u20096) months of treatment with psychotropic medications inducing metabolic disturbances (i.e., antipsychotics, mood stabilizers and some antidepressants) in 1135 patients from the PsyMetab cohort. Six highly correlated BMI phenotypes (i.e., BMI change and BMI slope after distinct durations of psychotropic treatment) were considered in the analyses. Our results showed that four novel loci were associated with altered BMI upon treatment at genome-wide significance (<jats:italic>p<\/jats:italic>\u2009&lt;\u20095\u2009\u00d7\u200910<jats:sup>\u22128<\/jats:sup>): rs7736552 (near <jats:italic>MAN2A1<\/jats:italic>), rs11074029 (in <jats:italic>SLCO3A1<\/jats:italic>), rs117496040 (near <jats:italic>DEFB1<\/jats:italic>) and rs7647863 (in <jats:italic>IQSEC1<\/jats:italic>). Associations between the four loci and alternative BMI-change phenotypes showed consistent effects. Replication analyses in 1622 UK Biobank participants under psychotropic treatment showed a consistent association between rs7736552 and BMI slope (<jats:italic>p<\/jats:italic>\u2009=\u20090.017). These findings provide new insights into metabolic side effects induced by psychotropic drugs and underline the need for future studies to replicate these associations in larger cohorts.<\/jats:p>","DOI":"10.1038\/s41380-023-02082-3","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T11:02:50Z","timestamp":1683889370000},"page":"2320-2327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis"],"prefix":"10.1038","volume":"28","author":[{"given":"Jennifer","family":"Sjaarda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Delacr\u00e9taz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6585-8492","authenticated-orcid":false,"given":"C\u00e9line","family":"Dubath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermine","family":"Laaboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-7194","authenticated-orcid":false,"given":"S\u00e9verine","family":"Crettol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ansermot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Gamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin Jessica","family":"Plessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7852-3803","authenticated-orcid":false,"given":"Armin","family":"von Gunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Conus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-7523","authenticated-orcid":false,"given":"Zoltan","family":"Kutalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-0230","authenticated-orcid":false,"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"2082_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72:334\u201341.","journal-title":"JAMA Psychiatry"},{"key":"2082_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorthoj","year":"2017","unstructured":"Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: A systematic review and meta-analysis. lancet Psychiatry. 2017;4:295\u2013301.","journal-title":"lancet Psychiatry"},{"key":"2082_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2012","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2012;8:114\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"2082_CR4","first-page":"61","volume":"2","author":"RR MacNeil","year":"2016","unstructured":"MacNeil RR, Muller DJ. Genetics of common antipsychotic-induced adverse effects. Mol Neuropsychiatry. 2016;2:61\u201378.","journal-title":"Mol Neuropsychiatry"},{"key":"2082_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/wps.20204","volume":"14","author":"CU Correll","year":"2015","unstructured":"Correll CU, Detraux J, De Lepeleire J, De, Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry: Off J World Psychiatr Assoc. 2015;14:119\u201336.","journal-title":"World Psychiatry: Off J World Psychiatr Assoc"},{"key":"2082_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.schres.2011.06.006","volume":"131","author":"FJ Diaz","year":"2011","unstructured":"Diaz FJ, Perez-Iglesias R, Mata I, Martinez-Garcia O, Vazquez-Barquero JL, de Leon J, et al. Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naive first-episode psychosis patients. Schizophr Res. 2011;131:82\u20139.","journal-title":"Schizophr Res"},{"key":"2082_CR7","doi-asserted-by":"publisher","first-page":"e33548","DOI":"10.1371\/journal.pone.0033548","volume":"7","author":"K Weston-Green","year":"2012","unstructured":"Weston-Green K, Huang XF, Deng C. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain. PloS one. 2012;7:e33548.","journal-title":"PloS one"},{"key":"2082_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbr.2009.09.032","volume":"207","author":"B Guesdon","year":"2010","unstructured":"Guesdon B, Denis RG, Richard D. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance. Behav Brain Res. 2010;207:14\u201320.","journal-title":"Behav Brain Res"},{"key":"2082_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/clpt.2011.97","volume":"90","author":"SL Balt","year":"2011","unstructured":"Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther. 2011;90:179\u201383.","journal-title":"Clin Pharmacol Ther"},{"key":"2082_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.pnpbp.2006.12.021","volume":"31","author":"S Ryu","year":"2007","unstructured":"Ryu S, Cho EY, Park T, Oh S, Jang WS, Kim SK, et al. -759 C\/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31:673\u20137.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2082_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","volume":"42","author":"JP Zhang","year":"2016","unstructured":"Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: A systematic review and meta-analysis. Schizophr Bull. 2016;42:1418\u201337.","journal-title":"Schizophr Bull"},{"key":"2082_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/mp.2011.109","volume":"17","author":"TA Lett","year":"2012","unstructured":"Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Muller DJ. Pharmacogenetics of antipsychotic-induced weight gain: Review and clinical implications. Mol Psychiatry. 2012;17:242\u201366.","journal-title":"Mol Psychiatry"},{"key":"2082_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015;518:197\u2013206.","journal-title":"Nature"},{"key":"2082_CR14","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/508S58a","volume":"508","author":"C Willyard","year":"2014","unstructured":"Willyard C. Heritability: The family roots of obesity. Nature 2014;508:S58\u201360.","journal-title":"Nature"},{"key":"2082_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrendo.2013.227","volume":"10","author":"RJ Loos","year":"2014","unstructured":"Loos RJ, Yeo GS. The bigger picture of FTO: The first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10:51\u201361.","journal-title":"Nat Rev Endocrinol"},{"key":"2082_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.302888","volume":"116","author":"T Rankinen","year":"2015","unstructured":"Rankinen T, Sarzynski MA, Ghosh S, Bouchard C. Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors? Circ Res. 2015;116:909\u201322.","journal-title":"Circ Res"},{"key":"2082_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.261","volume":"7","author":"AT Amare","year":"2017","unstructured":"Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7:e1007.","journal-title":"Transl Psychiatry"},{"key":"2082_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jad.2016.03.031","volume":"198","author":"L Quteineh","year":"2016","unstructured":"Quteineh L, Preisig M, Rivera M, Milaneschi Y, Castelao E, Gholam-Rezaee M, et al. Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression. J Affect Disord. 2016;198:43\u20139.","journal-title":"J Affect Disord"},{"key":"2082_CR19","first-page":"152","volume":"6","author":"P Toalson","year":"2004","unstructured":"Toalson P, Ahmed S, Hardy T, Kabinoff G. The metabolic syndrome in patients with severe mental illnesses. Prim Care Companion J Clin Psychiatry. 2004;6:152\u20138.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"2082_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","volume":"69","author":"AK Malhotra","year":"2012","unstructured":"Malhotra AK, Correll CU, Chowdhury NI, M\u00fcller DJ, Gregersen PK, Lee AT, et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry. 2012;69:904\u201312.","journal-title":"Arch Gen Psychiatry"},{"key":"2082_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/schbul\/sbv179","volume":"42","author":"H Yu","year":"2016","unstructured":"Yu H, Wang L, Lv L, Ma C, Du B, Lu T, et al. Genome-wide association study suggested the PTPRD polymorphisms were associated with weight gain effects of atypical antipsychotic medications. Schizophr Bull. 2016;42:814\u201323.","journal-title":"Schizophr Bull"},{"key":"2082_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/tpj.2015.59","volume":"16","author":"EJ Brandl","year":"2016","unstructured":"Brandl EJ, Tiwari AK, Zai CC, Nurmi EL, Chowdhury NI, Arenovich T, et al. Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample. Pharmacogenomics J. 2016;16:352\u20136.","journal-title":"Pharmacogenomics J"},{"key":"2082_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2019.07.022","volume":"212","author":"M Maciukiewicz","year":"2019","unstructured":"Maciukiewicz M, Tiwari AK, Zai CC, Gorbovskaya I, Laughlin CP, Nurmi EL, et al. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Schizophr Res. 2019;212:204\u201312.","journal-title":"Schizophr Res"},{"key":"2082_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0269881120907972","volume":"34","author":"SE Ter Hark","year":"2020","unstructured":"Ter Hark SE, Jamain S, Schijven D, Lin BD, Bakker MK, Boland-Auge A, et al. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort). J Psychopharmacol (Oxf, Engl). 2020;34:524\u201331.","journal-title":"J Psychopharmacol (Oxf, Engl)"},{"key":"2082_CR25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2013.187","volume":"70","author":"E Choong","year":"2013","unstructured":"Choong E, Quteineh L, Cardinaux JR, Gholam-Rezaee M, Vandenberghe F, Dobrinas M, et al. Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population. JAMA Psychiatry. 2013;70:1011\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2082_CR26","first-page":"1994","volume":"4","author":"E Choong","year":"2008","unstructured":"Choong E, Solida A, Lechaire C, Conus P, Eap CB. Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives. Rev Med Suisse. 2008;4:1994\u20139.","journal-title":"Rev Med Suisse"},{"key":"2082_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/0269881116645254","volume":"30","author":"SJ Cooper","year":"2016","unstructured":"Cooper SJ, Reynolds GP, Barnes T, England E, Haddad PM, Heald A, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol (Oxf, Engl). 2016;30:717\u201348.","journal-title":"J Psychopharmacol (Oxf, Engl)"},{"key":"2082_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 2015;4:7.","journal-title":"GigaScience"},{"key":"2082_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bib\/bbx012","volume":"19","author":"S Zhao","year":"2018","unstructured":"Zhao S, Jing W, Samuels DC, Sheng Q, Shyr Y, Guo Y. Strategies for processing and quality control of Illumina genotyping arrays. Brief Bioinforma. 2018;19:765\u201375.","journal-title":"Brief Bioinforma"},{"key":"2082_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/gepi.20516","volume":"34","author":"CC Laurie","year":"2010","unstructured":"Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, Bhangale T, et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol. 2010;34:591\u2013602.","journal-title":"Genet Epidemiol"},{"key":"2082_CR31","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics 2010;26:2867\u201373.","journal-title":"Bioinformatics"},{"key":"2082_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s10519-009-9281-0","volume":"39","author":"TM Beasley","year":"2009","unstructured":"Beasley TM, Erickson S, Allison DB. Rank-based inverse normal transformations are increasingly used, but are they merited? Behav Genet. 2009;39:580\u201395.","journal-title":"Behav Genet"},{"key":"2082_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"2082_CR34","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"2082_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50:1505\u201313.","journal-title":"Nat Genet"},{"key":"2082_CR36","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in \u223c700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641\u20139.","journal-title":"Hum Mol Genet"},{"key":"2082_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.2274","volume":"44","author":"AK Manning","year":"2012","unstructured":"Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44:659\u201369.","journal-title":"Nat Genet"},{"key":"2082_CR38","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274\u201383.","journal-title":"Nat Genet"},{"key":"2082_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343\u201352.","journal-title":"Nat Neurosci"},{"key":"2082_CR40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","volume":"51","author":"EA Stahl","year":"2019","unstructured":"Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793\u2013803.","journal-title":"Nat Genet"},{"key":"2082_CR41","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50:1593\u20139.","journal-title":"Nat Genet"},{"key":"2082_CR42","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","volume":"31","author":"M Arnold","year":"2015","unstructured":"Arnold M, Raffler J, Pfeufer A, Suhre K, Kastenm\u00fcller G. SNiPA: An interactive, genetic variant-centered annotation browser. Bioinformatics 2015;31:1334\u20136.","journal-title":"Bioinformatics"},{"key":"2082_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"Pulit SL, Stoneman C, Morris AP, Wood AR, Glastonbury CA, Tyrrell J, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet. 2019;28:166\u201374.","journal-title":"Hum Mol Genet"},{"key":"2082_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jaci.2019.09.035","volume":"145","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Guo Y, Shi H, Liu CL, Panganiban RA, Chung W, et al. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank. J Allergy Clin Immunol. 2020;145:537\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"2082_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","volume":"104","author":"G Kichaev","year":"2019","unstructured":"Kichaev G, Bhatia G, Loh PR, Gazal S, Burch K, Freund MK, et al. Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am J Hum Genet. 2019;104:65\u201375.","journal-title":"Am J Hum Genet"},{"key":"2082_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"W Song","year":"2020","unstructured":"Song W, Li D, Tao L, Luo Q, Chen L. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharmaceutica Sin B 2020;10:61\u201378.","journal-title":"Acta Pharmaceutica Sin B"},{"key":"2082_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium.","year":"2013","unstructured":"GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"2082_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000045961","volume":"88","author":"T Hiratsuka","year":"2001","unstructured":"Hiratsuka T, Nakazato M, Date Y, Mukae H, Matsukura S. Nucleotide sequence and expression of rat beta-defensin-1: its significance in diabetic rodent models. Nephron 2001;88:65\u201370.","journal-title":"Nephron"},{"key":"2082_CR49","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res. 2020;126:1549\u201364.","journal-title":"Circ Res"},{"key":"2082_CR50","doi-asserted-by":"publisher","first-page":"e0139155","DOI":"10.1371\/journal.pone.0139155","volume":"10","author":"A Delacretaz","year":"2015","unstructured":"Delacretaz A, Preisig M, Vandenberghe F, Saigi Morgui N, Quteineh L, Choong E, et al. Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression. PloS one. 2015;10:e0139155.","journal-title":"PloS one"},{"key":"2082_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/FPC.0000000000000313","volume":"27","author":"A Delacretaz","year":"2017","unstructured":"Delacretaz A, Lagares Santos P, Saigi Morgui N, Vandenberghe F, Glatard A, Gholam-Rezaee M, et al. Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs. Pharmacogenet Genomics. 2017;27:464\u201372.","journal-title":"Pharmacogenet Genomics"},{"key":"2082_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000353953","volume":"75","author":"JE Curran","year":"2013","unstructured":"Curran JE, McKay DR, Winkler AM, Olvera RL, Carless MA, Dyer TD, et al. Identification of pleiotropic genetic effects on obesity and brain anatomy. Hum Hered. 2013;75:136\u201343.","journal-title":"Hum Hered"},{"key":"2082_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/jamapsychiatry.2019.4188","volume":"77","author":"S Bahrami","year":"2020","unstructured":"Bahrami S, Steen NE, Shadrin A, O\u2019Connell K, Frei O, Bettella F, et al. Shared genetic loci between body mass index and major psychiatric disorders: A genome-wide association study. JAMA Psychiatry. 2020;77:503\u201312.","journal-title":"JAMA Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02082-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T08:06:05Z","timestamp":1698393965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02082-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02082-3","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Eap received honoraria for conferences or teaching CME courses from Forum pour la formation m\u00e9dicale, Janssen-Cilag, Lundbeck, Otsuka, Sandoz, Servier, Sunovion, Sysmex Suisse AG, Vifor-Pharma, and Zeller in the past 3 years. Dr. Crettol received honoraria for conferences or teaching CME courses from Forum f\u00fcr Medizinische Fortbildung. Dr. Vandenberghe received honoraria for conferences or teaching CME courses from Forum f\u00fcr Medizinische Fortbildung and Sysmex Suisse AG. Dr. Ansermot received honoraria for a conference from Sysmex Suisse AG. All other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was carried out in accordance with the Declaration of Helsinki, the Swiss law and local requirements. The study protocol, numbered 2017-01301, was approved by the Ethic committee of Vaud (CER-VD) with written informed consent from all subjects. This replication analyses have been conducted using the UK Biobank Resource under Application Number 16389.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}